» Articles » PMID: 32168345

Characterization of the Immune Cell Landscape of Patients with NAFLD

Overview
Journal PLoS One
Date 2020 Mar 14
PMID 32168345
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple factors are involved in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), but the exact immunological mechanisms that cause inflammation and fibrosis of the liver remain enigmatic. In this current study, cellular samples of a cohort of NAFLD patients (peripheral blood mononuclear cells (PBMC): n = 27, liver samples: n = 15) and healthy individuals (PBMC: n = 26, liver samples: n = 3) were analyzed using 16-color flow cytometry, and the frequency and phenotype of 23 immune cell subtypes was assessed. PBMC of NAFLD patients showed decreased frequencies of total CD3+, CD8+ T cells, CD56dim NK cells and MAIT cells, but elevated frequencies of CD4+ T cells and Th2 cells compared to healthy controls. Intrahepatic lymphocytes (IHL) of NAFLD patients showed decreased frequencies of total T cells, total CD8+ T cells, Vd2+γδ T cells, and CD56bright NK cells, but elevated frequencies of Vδ2-γδ T cells and CD56dim NK cells compared to healthy controls. The activating receptor NKG2D was significantly less frequently expressed among iNKT cells, total NK cells and CD56dim NK cells of PBMC of NAFLD patients compared to healthy controls. More strikingly, hepatic fibrosis as measured by fibroscan elastography negatively correlated with the intrahepatic frequency of total NK cells (r2 = 0,3737, p = 0,02). Hepatic steatosis as measured by controlled attenuation parameter (CAP) value negatively correlated with the frequency of circulating NKG2D+ iNKT cells (r2 = 0,3365, p = 0,0047). Our data provide an overview of the circulating and intrahepatic immune cell composition of NAFLD patients, and point towards a potential role of NK cells and iNKT cells for the regulation of hepatic fibrosis and steatosis in NAFLD.

Citing Articles

Examination of the causal role of immune cells in non-alcoholic fatty liver disease by a bidirectional Mendelian randomization study.

Li Y, Lv X, Lin J, Li S, Lin G, Huang Z Open Med (Wars). 2025; 20(1):20251154.

PMID: 39989616 PMC: 11843165. DOI: 10.1515/med-2025-1154.


Active role of the immune system in metabolic dysfunction-associated steatotic liver disease.

Mori T, Yoshio S, Kakazu E, Kanto T Gastroenterol Rep (Oxf). 2024; 12:goae089.

PMID: 39411101 PMC: 11479709. DOI: 10.1093/gastro/goae089.


Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.

Rabiu L, Zhang P, Afolabi L, Saliu M, Dabai S, Suleiman R J Gastroenterol. 2024; 59(12):1053-1078.

PMID: 39400718 DOI: 10.1007/s00535-024-02157-0.


Identification of novel targets associated with cholesterol metabolism in nonalcoholic fatty liver disease: a comprehensive study using Mendelian randomization combined with transcriptome analysis.

Chen J, Rao H, Zheng X Front Genet. 2024; 15:1464865.

PMID: 39359475 PMC: 11445148. DOI: 10.3389/fgene.2024.1464865.


Macrophages and T cells in metabolic disorder-associated cancers.

Taranto D, Kloosterman D, Akkari L Nat Rev Cancer. 2024; 24(11):744-767.

PMID: 39354070 DOI: 10.1038/s41568-024-00743-1.


References
1.
Stiglund N, Strand K, Cornillet M, Stal P, Thorell A, Zimmer C . Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease. Front Immunol. 2019; 10:1255. PMC: 6558016. DOI: 10.3389/fimmu.2019.01255. View

2.
Kleiner D, Brunt E, Van Natta M, Behling C, Contos M, Cummings O . Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41(6):1313-21. DOI: 10.1002/hep.20701. View

3.
Kotas M, Lee H, Gillum M, Annicelli C, Guigni B, Shulman G . Impact of CD1d deficiency on metabolism. PLoS One. 2011; 6(9):e25478. PMC: 3183002. DOI: 10.1371/journal.pone.0025478. View

4.
Angulo P, Kleiner D, Dam-Larsen S, Adams L, Bjornsson E, Charatcharoenwitthaya P . Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(2):389-97.e10. PMC: 4516664. DOI: 10.1053/j.gastro.2015.04.043. View

5.
Wolf M, Adili A, Piotrowitz K, Abdullah Z, Boege Y, Stemmer K . Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell. 2014; 26(4):549-64. DOI: 10.1016/j.ccell.2014.09.003. View